tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

HRTX Stock Latest News

Heron Therapeutics names Brett Fleshman as Chief Business Officer
The FlyHeron Therapeutics names Brett Fleshman as Chief Business Officer
17d ago
HRTX
Heron reaffirms FY24 revenue view $138.0M-$158.0M, consensus $147.8M
PremiumThe Fly
Heron reaffirms FY24 revenue view $138.0M-$158.0M, consensus $147.8M
1M ago
HRTX
Heron Therapeutics reports Q2 EPS (6c), consensus (4c)
PremiumThe Fly
Heron Therapeutics reports Q2 EPS (6c), consensus (4c)
1M ago
HRTX
Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance
PremiumPress Releases
Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance
1M ago
HRTX
Is HRTX a Buy, Before Earnings?
PremiumPre-Earnings
Is HRTX a Buy, Before Earnings?
2M ago
HRTX
Heron Therapeutics management to meet virtually with Needham
PremiumThe FlyHeron Therapeutics management to meet virtually with Needham
2M ago
HRTX
Heron Therapeutics’ Zynrelef included in 2025 Non-Opioid Policy for Pain Relief
Premium
The Fly
Heron Therapeutics’ Zynrelef included in 2025 Non-Opioid Policy for Pain Relief
2M ago
HRTX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
EBS
ARCT
Heron Therapeutics selloff creates buying opportunity, says Northland
PremiumThe Fly
Heron Therapeutics selloff creates buying opportunity, says Northland
3M ago
HRTX
PCRX
Heron Therapeutics’ ZYNRELEF Review Date Set by FDA
PremiumCompany Announcements
Heron Therapeutics’ ZYNRELEF Review Date Set by FDA
3M ago
8K
HRTX
Heron Therapeutics announces acceptance of PAS application for ZYNRELE
PremiumThe Fly
Heron Therapeutics announces acceptance of PAS application for ZYNRELE
3M ago
HRTX
Heron Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Heron Therapeutics initiated with a Buy at Rodman & Renshaw
3M ago
HRTX
Heron Therapeutics Submits ZYNRELEF® Supplement to FDA
PremiumCompany AnnouncementsHeron Therapeutics Submits ZYNRELEF® Supplement to FDA
4M ago
8K
HRTX
Heron announces PAS submission to FDA for ZYNRELEF
Premium
The Fly
Heron announces PAS submission to FDA for ZYNRELEF
4M ago
HRTX
Heron Therapeutics sees FY24 adjusted EBITDA ($22.0M)-$3.0M
Premium
The Fly
Heron Therapeutics sees FY24 adjusted EBITDA ($22.0M)-$3.0M
5M ago
HRTX
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
PremiumPress Releases
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
5M ago
HRTX
Heron Therapeutics reports Q1 EPS (2c), consensus (9c)
PremiumThe Fly
Heron Therapeutics reports Q1 EPS (2c), consensus (9c)
5M ago
HRTX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
BMRN
HRTX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
UNH
ABIO
Heron Therapeutics management to meet virtually with Northland
PremiumThe FlyHeron Therapeutics management to meet virtually with Northland
5M ago
HRTX
Heron Therapeutics initiated with an Overweight at Capital One
Premium
The Fly
Heron Therapeutics initiated with an Overweight at Capital One
5M ago
HRTX
Heron Therapeutics management to meet virtually with Northland
Premium
The Fly
Heron Therapeutics management to meet virtually with Northland
5M ago
HRTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >